Invasive Aspergillosis: Resistance to Antifungal Drugs

Aspergillus fumigatus Strains with Mutations in thecyp51AGene Do Not Always Show Phenotypic Resistance to Itraconazole, Voriconazole, or Posaconazole

(2011) Pilar Escribano et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Cryptic Species and Azole Resistance in the Aspergillus niger Complex

(2011) Susan J. Howard et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Azole Resistance in Aspergillus fumigatus Isolates from the ARTEMIS Global Surveillance Study Is Primarily Due to the TR/L98H Mutation in thecyp51AGene

(2011) Shawn R. Lockhart et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

The structure–function relationship of the Aspergillus fumigatus cyp51A L98H conversion by site-directed mutagenesis: The mechanism of L98H azole resistance

(2011) Eveline Snelders et al.   FUNGAL GENETICS AND BIOLOGY

Comment on: Low prevalence of resistance to azoles in Aspergillus fumigatus in a French cohort of patients treated for haematological malignancies

(2011) P. E. Verweij et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Randomized Comparison of Safety and Pharmacokinetics of Caspofungin, Liposomal Amphotericin B, and the Combination of Both in Allogeneic Hematopoietic Stem Cell Recipients

(2010) A. H. Groll et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

In vitrosusceptibility testing inAspergillusspecies: an update

(2010) Cornelia Lass-Flörl   Future Microbiology

Low prevalence of resistance to azoles in Aspergillus fumigatus in a French cohort of patients treated for haematological malignancies

(2010) A. Alanio et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Use of Epidemiological Cutoff Values To Examine 9-Year Trends in Susceptibility of Aspergillus Species to the Triazoles

(2010) M. Pfaller et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Wild-Type MIC Distributions and Epidemiological Cutoff Values for the Triazoles and Six Aspergillus spp. for the CLSI Broth Microdilution Method (M38-A2 Document)

(2010) A. Espinel-Ingroff et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Aspergillus niger: an unusual cause of invasive pulmonary aspergillosis

(2010) A. K. Person et al.   JOURNAL OF MEDICAL MICROBIOLOGY

Acquired resistance to voriconazole and itraconazole in a patient with pulmonary aspergilloma

(2010) Bahrie Bellete et al.   MEDICAL MYCOLOGY

PULMONARY ASPERGILLOSIS CAUSED BY A PAN-AZOLE-RESISTANT ASPERGILLUS FUMIGATUS IN A 10-YEAR-OLD BOY

(2010) Valtyr S. Thors et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Comparison of Assessment of Oxygen Consumption, Etest, and CLSI M38-A2 Broth Microdilution Methods for Evaluation of the Susceptibility of Aspergillus fumigatus to Posaconazole

(2009) R. Araujo et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Possible Environmental Origin of Resistance of Aspergillus fumigatus to Medical Triazoles

(2009) E. Snelders et al.   APPLIED AND ENVIRONMENTAL MICROBIOLOGY

Azole-resistance in Aspergillus: Proposed nomenclature and breakpoints

(2009) Paul E. Verweij et al.   DRUG RESISTANCE UPDATES

Aspergillus alabamensis, a New Clinically Relevant Species in the SectionTerrei

(2009) S. Arunmozhi Balajee et al.   EUKARYOTIC CELL

Patterns of Susceptibility of Aspergillus Isolates Recovered from Patients Enrolled in the Transplant-Associated Infection Surveillance Network

(2009) J. W. Baddley et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Molecular Identification of Aspergillus Species Collected for the Transplant-Associated Infection Surveillance Network

(2009) S. A. Balajee et al.   JOURNAL OF CLINICAL MICROBIOLOGY

In Vitro Susceptibility of Clinical Isolates of Aspergillus spp. to Anidulafungin, Caspofungin, and Micafungin: a Head-to-Head Comparison Using the CLSI M38-A2 Broth Microdilution Method

(2009) M. A. Pfaller et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Azole resistance in Aspergillus fumigatus: a side-effect of environmental fungicide use?

(2009) Paul E Verweij et al.   LANCET INFECTIOUS DISEASES

Aspergillus flavus: an emerging non-fumigatus Aspergillusspecies of significance

(2009) Suganthini Krishnan et al.   MYCOSES

Invasive aspergillosis: epidemiology and environmental study in haematology patients (Sfax, Tunisia)

(2009) I. Hadrich et al.   MYCOSES

Aspergillus terreus Accessory Conidia Are Unique in Surface Architecture, Cell Wall Composition and Germination Kinetics

(2009) Eszter Deak et al.   PLoS One

Activities of Antifungal Agents against Yeasts and Filamentous Fungi: Assessment according to the Methodology of the European Committee on Antimicrobial Susceptibility Testing

(2008) C. Lass-Florl et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

In Vitro Activities of Various Antifungal Drugs against Aspergillus terreus: Global Assessment Using the Methodology of the European Committee on Antimicrobial Susceptibility Testing

(2008) C. Lass-Florl et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Clinical Isolates of Aspergillus Species Remain Fully Susceptible to Voriconazole in the Post-Voriconazole Era

(2008) J. Guinea et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Establishing In Vitro-In Vivo Correlations for Aspergillus fumigatus: the Challenge of Azoles versus Echinocandins

(2008) M. C. Arendrup et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Breakthrough Aspergillus fumigatus and Candida albicans Double Infection during Caspofungin Treatment: Laboratory Characteristics and Implication for Susceptibility Testing

(2008) M. C. Arendrup et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

In Vitro Antifungal Activities of Isavuconazole (BAL4815), Voriconazole, and Fluconazole against 1,007 Isolates of Zygomycete, Candida, Aspergillus, Fusarium, and Scedosporium Species

(2008) J. Guinea et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Aspergillus Section Fumigati: Antifungal Susceptibility Patterns and Sequence-Based Identification

(2008) L. Alcazar-Fuoli et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Potential Basis for Amphotericin B Resistance in Aspergillus terreus

(2008) G. Blum et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America

(2008) Thomas J. Walsh et al.   CLINICAL INFECTIOUS DISEASES

Defining Responses to Therapy and Study Outcomes in Clinical Trials of Invasive Fungal Diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer Consensus Criteria

(2008) Brahm H. Segal et al.   CLINICAL INFECTIOUS DISEASES

EUCAST Technical Note on the method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for conidia–forming moulds

(2008)   CLINICAL MICROBIOLOGY AND INFECTION

First case of breakthrough pulmonary Aspergillus niveus infection in a patient after allogeneic hematopoietic stem cell transplantation

(2008) Jutta Auberger et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Aspergillus calidoustussp. nov., Causative Agent of Human Infections Previously Assigned toAspergillus ustus

(2008) János Varga et al.   EUKARYOTIC CELL

Isavuconazole: a new and promising antifungal triazole for the treatment of invasive fungal infections

(2008) Jesús Guinea et al.   Future Microbiology

In Vitro Survey of Triazole Cross-Resistance among More than 700 Clinical Isolates of Aspergillus Species

(2008) M. A. Pfaller et al.   JOURNAL OF CLINICAL MICROBIOLOGY

In vitrosusceptibility-testing inAspergillusspecies

(2008) Cornelia Lass-Flörl et al.   MYCOSES

Emergence of Azole Resistance in Aspergillus fumigatus and Spread of a Single Resistance Mechanism

(2008) Eveline Snelders et al.   PLOS MEDICINE

Voriconazole Therapeutic Drug Monitoring in Patients with Invasive Mycoses Improves Efficacy and Safety Outcomes

(2007) A. Pascual et al.   CLINICAL INFECTIOUS DISEASES

Caspofungin-resistant Aspergillus flavus after heart transplantation and mechanical circulatory support: a case report

(2007) S. Eschertzhuber et al.   Transplant Infectious Disease